Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting

Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting

Bibliographic Details
Main Authors: F. Roghmann, R. Wirtz, A. Santiago-Walker, J. Jarczyk, M.C. Kriegmair, T.S. Worst, D. Sikic, S. Wach, H. Taubert, V. Weyerer, R. Stoehr, K. Tully, F. Zengerling, C. Bolenz, J. Breyer, M. Burger, S. Porubsky, A. Hartmann, P. Erben, M. Eckstein, H. Jütte
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320331372
id doaj-a1fce527abd744e19c0f665883ecf543
record_format Article
spelling doaj-a1fce527abd744e19c0f665883ecf5432020-12-30T04:15:43ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e830Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line settingF. RoghmannR. WirtzA. Santiago-WalkerJ. JarczykM.C. KriegmairT.S. WorstD. SikicS. WachH. TaubertV. WeyererR. StoehrK. TullyF. ZengerlingC. BolenzJ. BreyerM. BurgerS. PorubskyA. HartmannP. ErbenM. EcksteinH. Jüttehttp://www.sciencedirect.com/science/article/pii/S2666168320331372
collection DOAJ
language English
format Article
sources DOAJ
author F. Roghmann
R. Wirtz
A. Santiago-Walker
J. Jarczyk
M.C. Kriegmair
T.S. Worst
D. Sikic
S. Wach
H. Taubert
V. Weyerer
R. Stoehr
K. Tully
F. Zengerling
C. Bolenz
J. Breyer
M. Burger
S. Porubsky
A. Hartmann
P. Erben
M. Eckstein
H. Jütte
spellingShingle F. Roghmann
R. Wirtz
A. Santiago-Walker
J. Jarczyk
M.C. Kriegmair
T.S. Worst
D. Sikic
S. Wach
H. Taubert
V. Weyerer
R. Stoehr
K. Tully
F. Zengerling
C. Bolenz
J. Breyer
M. Burger
S. Porubsky
A. Hartmann
P. Erben
M. Eckstein
H. Jütte
Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
European Urology Open Science
author_facet F. Roghmann
R. Wirtz
A. Santiago-Walker
J. Jarczyk
M.C. Kriegmair
T.S. Worst
D. Sikic
S. Wach
H. Taubert
V. Weyerer
R. Stoehr
K. Tully
F. Zengerling
C. Bolenz
J. Breyer
M. Burger
S. Porubsky
A. Hartmann
P. Erben
M. Eckstein
H. Jütte
author_sort F. Roghmann
title Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
title_short Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
title_full Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
title_fullStr Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
title_full_unstemmed Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
title_sort prognostic role of fgfr alterations and fgfr mrna expression in metastatic urothelial cancer treated with anti-pd(l1) inhibitors in first and second line setting
publisher Elsevier
series European Urology Open Science
issn 2666-1683
publishDate 2020-07-01
url http://www.sciencedirect.com/science/article/pii/S2666168320331372
work_keys_str_mv AT froghmann prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT rwirtz prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT asantiagowalker prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT jjarczyk prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT mckriegmair prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT tsworst prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT dsikic prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT swach prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT htaubert prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT vweyerer prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT rstoehr prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT ktully prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT fzengerling prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT cbolenz prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT jbreyer prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT mburger prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT sporubsky prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT ahartmann prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT perben prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT meckstein prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
AT hjutte prognosticroleoffgfralterationsandfgfrmrnaexpressioninmetastaticurothelialcancertreatedwithantipdl1inhibitorsinfirstandsecondlinesetting
_version_ 1724366882258026496

Similar Items